Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Indolent Non-Hodgkin LymphomaMantle Cell LymphomaChronic Lymphocytic Leukemia

Interventions

DRUG

SAR245409

Pharmaceutical form:capsule Route of administration: oral

Trial Locations (3)

Investigational Site Number 840002, Charleston

Investigational Site Number 840006, Augusta

Investigational Site Number 840004, Aurora